Lundbeck Stock price Nasdaq Copenhagen

Equities

LUN

DK0061804697

Pharmaceuticals

Delayed Nasdaq Copenhagen 11:59:48 2024-03-27 am EDT 5-day change 1st Jan Change
28.62 DKK +2.88% Intraday chart for Lundbeck -0.49% -17.14%
Sales 2024 * 20.95B 3.03B Sales 2025 * 21.83B 3.16B Capitalization 32.04B 4.64B
Net income 2024 * 2.98B 431M Net income 2025 * 3.41B 493M EV / Sales 2024 * 1.32 x
Net cash position 2024 * 4.4B 637M Net cash position 2025 * 8.03B 1.16B EV / Sales 2025 * 1.1 x
P/E ratio 2024 *
11.1 x
P/E ratio 2025 *
9.64 x
Employees 5,681
Yield 2024 *
2.65%
Yield 2025 *
3.05%
Free-Float 30.83%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.88%
Current month-17.14%
Current year-17.14%
More quotes
3 years
28.02
Extreme 28.02
44.94
5 years
28.02
Extreme 28.02
61.78
10 years
22.30
Extreme 22.3
95.54
More quotes
Date Price Change Volume
24-03-27 28.62 +2.88% 163,332
24-03-26 27.82 -0.50% 82,884
24-03-25 27.96 +0.58% 99,297
24-03-22 27.8 -1.42% 127,612
24-03-21 28.2 -1.95% 69,660

Delayed Quote Nasdaq Copenhagen, March 27, 2024 at 11:59 am EDT

More quotes
H Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. It is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer's disease, Bipolar disorder, depression, epilepsy, Huntington's disease, Parkinson's disease and schizophrenia. Its product portfolio includes: Cipralex for the treatment of depression and anxiety disorders, Ebixa for the treatment of Alzheimer's disease, Azilect for the treatment of Parkinson's disease, Xenazine for the treatment of Huntington's disease and Sabril for the treatment of epilepsy, among others. The Company operates through a number of subsidiaries, such as Lundbeck SAS, Lundbeck GmbH, SIA Lundbeck Latvia and Lundbeck LLC.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
33.22 DKK
Average target price
38.79 DKK
Spread / Average Target
+16.77%
Consensus
  1. Stock
  2. Equities
  3. Stock H. Lundbeck A/S
  4. Stock Lundbeck - Nasdaq Copenhagen